Kellie J. Archer
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
221
Citations
8,447
Est. group size
~14
Recurring co-author estimate
Active years
41
Publishing since 1986
Kellie J. Archer develops statistical and computational methods for analyzing complex biological data, particularly high-dimensional genomic and survival data related to cancer and other diseases. Her work spans building new statistical models (such as cure models for survival analysis) and applying them to real biomedical questions like cancer classification, liver disease, kidney transplant outcomes, and forensic science. This research combines biostatistics, bioinformatics, and clinical collaboration to help interpret large-scale molecular datasets.
Publication output has grown notably over the last decade, rising from a few papers per year around 2017-2018 to a peak of 26 in 2023, with more moderate activity in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Epithelial-Immune-Stromal Interactions Define Divergent Repair and Fibrosis Pathways After Acute Kidney Injury in Human Renal Transplants
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Mixture Cure Models
International Encyclopedia of Statistical Science · 2025
- How Much Training Data Does AI Need?
Radiology Artificial Intelligence · 2025
- Fitting high-dimensional mixture cure models using the hdcuremodels R package
Computer Methods and Programs in Biomedicine · 2025
- Penalized Bayesian forward continuation ratio model with application to high-dimensional data with discrete survival outcomes
PLoS ONE · 2024
- Abstract 6128: Association between neighborhood disinvestment and all-cause survival moderated by epigenetic age among women with breast cancer
Cancer Research · 2024
- hdcuremodels: High-Dimensional Cure Models
2024
- Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy
Journal of Lipid Research · 2023
- Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications
BMC Women s Health · 2023
- Preliminary assessment of three quantitative approaches for estimating time-since-deposition from autofluorescence and morphological profiles of cell populations from forensic biological samples
PLoS ONE · 2023
- Comparison of three quantitative approaches for estimating time-since-deposition from autofluorescence and morphological profiles of cell populations from forensic biological samples
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Supplementary Figure 1 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
2023
- Supplementary Table 3 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
2023
- Supplementary Figure 1 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
2023
- Supplementary Table 2 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
2023
- Blood×7
- PLoS ONE×6
- Nature Communications×3
- Briefings in Bioinformatics×3
- Scientific Reports×2
- Kevin R. Coombes
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Maciej Pietrzak
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Elnaz Pashaei
Biochemistry, Genetics and Molecular Biology · Indiana University
- Juexin Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Qianfan Wu
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile